Skip to content

Public FDA record

Z-0874-05: Nichols Advantage TSH - Third Generation

Recall record Z-0874-05 for Nichols Institute Diagnostics. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0874-05
Company in FDA record
Nichols Institute Diagnostics
FDA record creation date
Jun 25, 2015
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Does not meet performance claims in the labeling.

Source facts

Action
Firm sent recall letter and response form April 28, 2005. Firm will follow-up to nonrespondants.
Initiated
2005-04-28
Root cause
Other
Terminated
2012-03-16
Distribution
Nationwide, Germany, Greece and Spain
Recall number
Z-0874-05
Recall status
Terminated
CDRH record ID
38845
FDA record created
2015-06-25
Recall event number
31976

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗